Mineralys Therapeutics
Mineralys Therapeutics raises $287.5M Public Offering
Quick Facts
Mineralys Therapeutics: Public Offering Funding Round
Mineralys Therapeutics has successfully raised $287.5M in Public Offering funding.
Company Overview
Clinical-stage biopharma developing lorundrostat for hypertension treatment
Funding Details
The Public Offering round was led by Public Markets.
Company Information
- Headquarters: San Francisco, CA
- Founded: 2019
- Employees: 80+
- Category: HealthTech
Investment
Mineralys Therapeutics plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Public Markets: Verified investor in Public Offering
Key Investors
About the Author
Related Company Reports
AccelerateStack Platform raises $75M Series C at $226M valuation
AccelerateStack Platform secures $75M in Series C funding led by Intel Capital, reaching $226M valuation as it accelerates growth in the healthtech sector.
DermaSensor raises $16M Series B at $85M valuation
DermaSensor raises $16M in Series B at $85M valuation. AI-powered skin cancer screening device for early detection...
Devoted Health Partners Headquarters - Office Location & Address
Discover Devoted Health Partners's headquarters at 100 2nd Ave, Waltham, MA 02451. Medicare Advantage insurance. Learn about the office facilities and work environment.
